Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C91710
http://purl.obolibrary.org/obo/NCIT_C91710
|
|---|---|
| Preferred Name | MAGE-A3 Peptide Vaccine |
| Definitions |
A peptide cancer vaccine comprised of a peptide derived from the human melanoma antigen A3 (MAGE-A3), with potential immunostimulating and antineoplastic activities. Upon administration, MAGE-A3 peptide vaccine may stimulate the immune system to mount a cytotoxic T-cell (CTL) response against tumor cells expressing MAGE-A3, resulting in tumor cell lysis. MAGE-A3, a tumor-associated antigen (TAA), is overexpressed by a variety of cancer cell types.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A peptide cancer vaccine comprised of a peptide derived from the human melanoma antigen A3 (MAGE-A3), with potential immunostimulating and antineoplastic activities. Upon administration, MAGE-A3 peptide vaccine may stimulate the immune system to mount a cytotoxic T-cell (CTL) response against tumor cells expressing MAGE-A3, resulting in tumor cell lysis. MAGE-A3, a tumor-associated antigen (TAA), is overexpressed by a variety of cancer cell types. |
|---|---|
| prefLabel | MAGE-A3 Peptide Vaccine
|
| label | MAGE-A3 Peptide Vaccine
|
| PDQ_Closed_Trial_Search_ID | 391278
|
| code | C91710
|
| Has_Target | |
| prefixIRI | NCIT:C91710
|
| in_subset |
See more
See less
|
| Display_Name | MAGE-A3 Peptide Vaccine
|
| Preferred_Name | MAGE-A3 Peptide Vaccine
|
| Contributing_Source | CTRP
|
| Maps_To | MAGE-A3 Peptide Vaccine
|
| NCI_Drug_Dictionary_ID | 391278
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 391278
|
| Semantic_Type |
Amino Acid, Peptide, or Protein
Pharmacologic Substance
|
| UMLS_CUI | C1541478
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |